Business Description
InventisBio Co Ltd
ISIN : CNE100005Q22
Share Class Description:
SHSE:688382: Class ATotal Employee Number:
182Compare
Compare
Traded in other countries / regions
688382.China Index Membership
SSE Composite Index IPO Date
2022-07-25Description
InventisBio Co Ltd is an innovative drug research and development enterprise based in China with a global perspective, focusing on major diseases such as tumors and metabolic diseases. It has independently developed a series of innovative targeted drugs with patent protection, covering non-small cell lung cancer, breast cancer, colorectal cancer and other solid tumors, as well as hyperuricemia and metabolic diseases such as gout.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 70.59 | |||||
Equity-to-Asset | 0.93 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.06 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 60.55 | |||||
Beneish M-Score | -2.74 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 17.1 | |||||
3-Year EPS without NRI Growth Rate | 15.7 | |||||
3-Year FCF Growth Rate | 33.3 | |||||
3-Year Book Growth Rate | -11.7 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 164.05 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 49.07 | |||||
9-Day RSI | 46.35 | |||||
14-Day RSI | 46.43 | |||||
3-1 Month Momentum % | 6.1 | |||||
6-1 Month Momentum % | -5.72 | |||||
12-1 Month Momentum % | -56.36 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 15.29 | |||||
Quick Ratio | 15.29 | |||||
Cash Ratio | 13.89 | |||||
Days Sales Outstanding | 633.66 | |||||
Days Payable | 4701.04 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.2 | |||||
Shareholder Yield % | 0.02 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 92.31 | |||||
Operating Margin % | -507.97 | |||||
Net Margin % | -468.21 | |||||
EBITDA Margin % | -466.89 | |||||
FCF Margin % | -340.73 | |||||
OCF Margin % | -330.52 | |||||
ROE % | -21.37 | |||||
ROA % | -19.9 | |||||
ROIC % | -288.08 | |||||
3-Year ROIIC % | -560.41 | |||||
ROC (Joel Greenblatt) % | -350.45 | |||||
ROCE % | -21.07 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 154.68 | |||||
PB Ratio | 7.99 | |||||
Price-to-Tangible-Book | 8.02 | |||||
EV-to-EBIT | -29.33 | |||||
EV-to-EBITDA | -29.33 | |||||
EV-to-Revenue | 136.96 | |||||
EV-to-FCF | -40.2 | |||||
Price-to-GF-Value | 1.78 | |||||
| Price-to-Net-Current-Asset-Value | 8.36 | |||||
| Price-to-Net-Cash | 9.28 | |||||
Earnings Yield (Greenblatt) % | -3.41 | |||||
FCF Yield % | -2.15 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
InventisBio Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 71.445 | ||
| EPS (TTM) (Â¥) | -0.58 | ||
| Beta | 1.4514 | ||
| 3-Year Sharpe Ratio | 0.41 | ||
| 3-Year Sortino Ratio | 0.74 | ||
| Volatility % | 41.51 | ||
| 14-Day RSI | 46.43 | ||
| 14-Day ATR (Â¥) | 1.397121 | ||
| 20-Day SMA (Â¥) | 20.408 | ||
| 12-1 Month Momentum % | -56.36 | ||
| 52-Week Range (Â¥) | 15.58 - 45.5 | ||
| Shares Outstanding (Mil) | 579.59 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
InventisBio Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
InventisBio Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
InventisBio Co Ltd Frequently Asked Questions
What is InventisBio Co Ltd(SHSE:688382)'s stock price today?
The current price of SHSE:688382 is ¥19.49. The 52 week high of SHSE:688382 is ¥45.50 and 52 week low is ¥15.58.
When is next earnings date of InventisBio Co Ltd(SHSE:688382)?
The next earnings date of InventisBio Co Ltd(SHSE:688382) is .
Does InventisBio Co Ltd(SHSE:688382) pay dividends? If so, how much?
InventisBio Co Ltd(SHSE:688382) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on InventisBio Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers